Result of AGM

RNS Number : 4530V

IXICO plc

30 January 2017

 

30 January 2017

IXICO plc

("IXICO" or the "Company")

Results of AGM

IXICO plc (AIM: IXI), the brain health company, today announces that that all resolutions put to its Annual General Meeting held earlier today were duly passed.

For further information please contact:

IXICO plc Susan Lowther, Chief Financial Officer and Company Secretary                                                                                    Tel: [phone]
Shore Capital (Nomad and Broker) Bidhi Bhoma / Edward Mansfield                                    Tel: [phone]
FTI Consulting Limited (Investor Relations) Simon Conway/Mo Noonan/Matthew Moss               Tel: [phone]

About IXICO

IXICO's innovative and proprietary digital healthcare technologies help those involved in researching and treating serious diseases to capture and analyse clinical data to make rapid, informed decisions.  In clinical research this includes the phenotyping of patients, quantification of disease pathology and measurement of patient outcomes.  In clinical practice the mobile health and digital decision support technologies aid diagnosis, patient engagement and monitoring. IXICO is also collaborating with partners to develop companion digital health products targeted at improving patient outcomes.

The Company's brain health focus includes Alzheimer's disease, Huntington's disease, multiple sclerosis, Parkinson's disease, behavioural health, child and adolescent mental health.

More information is available on www.ixico.com

 

END

 

 

RAGOKKDBKBKDKDN